Pornlada Likasitwatanakul
Overview
Explore the profile of Pornlada Likasitwatanakul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang J, Likasitwatanakul P, Deshmukh S, Wu S, Kwon J, Toye E, et al.
Clin Cancer Res
. 2025 Jan;
31(5):936-948.
PMID: 39745364
Purpose: Around 10% to 15% of prostate cancers harbor recurrent aberrations in the Forkhead Box A1 gene, FOXA1, whereby the alteration type and the effect on the forkhead (FKH) domain...
2.
Likasitwatanakul P, Li Z, Doan P, Spisak S, Raghawan A, Liu Q, et al.
bioRxiv
. 2024 Dec;
PMID: 39713466
Dysregulated epigenetic programs that restrict differentiation, reactivate fetal genes, and confer phenotypic plasticity are critical to colorectal cancer (CRC) development. By screening a small molecule library targeting epigenetic regulators using...
3.
Miller C, Likasitwatanakul P, Toye E, Hwang J, Antonarakis E
Expert Rev Anticancer Ther
. 2024 Sep;
24(11):1085-1100.
PMID: 39275993
Introduction: Prostate cancer continues to be a major cause of morbidity and mortality for men worldwide. Enzalutamide, a second-generation non-steroidal antiandrogen that blocks androgen receptor (AR) transcriptional activity, is a...
4.
Bergom H, Boytim E, McSweeney S, Sadeghipour N, Elliott A, Passow R, et al.
JCI Insight
. 2024 Aug;
9(20).
PMID: 39207857
BACKGROUNDProstate cancer (PC) is driven by aberrant signaling of the androgen receptor (AR) or its ligands, and androgen deprivation therapies (ADTs) are a cornerstone of treatment. ADT responsiveness may be...
5.
Chauhan A, Likasitwatanakul P, Ahmed A, Sibley S
Cureus
. 2024 May;
16(4):e58741.
PMID: 38779292
Humoral hypercalcemia of malignancy (HHM) comprises the majority of cases with malignancy-related hypercalcemia and is mediated by elevated parathyroid hormone-related peptide (PTHrP). HHM is rare in cholangiocarcinoma and has been...
6.
Prosz A, Sahgal P, Huffman B, Sztupinszki Z, Morris C, Chen D, et al.
NPJ Precis Oncol
. 2024 May;
8(1):98.
PMID: 38710943
No abstract available.
7.
Prosz A, Sahgal P, Huffman B, Sztupinszki Z, Morris C, Chen D, et al.
NPJ Precis Oncol
. 2024 Apr;
8(1):87.
PMID: 38589664
Homologous recombination (HR) and nucleotide excision repair (NER) are the two most frequently disabled DNA repair pathways in cancer. HR-deficient breast, ovarian, pancreatic and prostate cancers respond well to platinum...
8.
Spisak S, Chen D, Likasitwatanakul P, Doan P, Li Z, Bala P, et al.
Nat Commun
. 2024 Mar;
15(1):2230.
PMID: 38472198
Aberrant stem cell-like activity and impaired differentiation are central to the development of colorectal cancer (CRC). To identify functional mediators of these key cellular programs, we engineer a dual endogenous...
9.
Spisak S, Chen D, Likasitwatanakul P, Doan P, Li Z, Bala P, et al.
bioRxiv
. 2024 Jan;
PMID: 38293113
Aberrant stem cell-like activity and impaired differentiation are central to the development of colorectal cancer (CRC). To identify functional mediators that regulate these key cellular programs in CRC, we developed...
10.
Laphanuwat P, Likasitwatanakul P, Sittithumcharee G, Thaphaengphan A, Chomanee N, Suppramote O, et al.
J Cell Sci
. 2018 Jun;
131(12).
PMID: 29880532
Expression of cyclin D1 () is required for cancer cell survival and proliferation. This is presumably due to the role of cyclin D1 in inactivation of the RB tumor suppressor....